Showing results (2091-2100 of 2,249) with videos related to

Sort By:
Pageof 225
Ebiomedicine|December 5, 2025
Maternal antibodies shape infant immune response development in an epitope-specific mannerHelle Sadam, Regina Maruste, Annika Rähni, et al.
European Journal of Gastroenterology & Hepatology|July 27, 2000
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative ResearchS Touzet, L Kraemer, C Colin, et al.
Blood|July 10, 2014
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapyHartmut Döhner, Michael Lübbert, Walter Fiedler, et al.
Ophthalmology and Therapy|June 23, 2026
Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network ReportKatharina Heck, Katja Hatz, Marco Cattaneo, et al.
Translational Psychiatry|November 7, 2020
Fractionating autism based on neuroanatomical normative modelingMariam Zabihi, Dorothea L Floris, Seyed Mostafa Kia, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 7, 2018
Clinical characteristics associated with paedophilia and child sex offending - Differentiating sexual preference from offence statusHannah Gerwinn, Simone Weiß, Gilian Tenbergen, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|February 26, 2019
Dissecting the Heterogeneous Cortical Anatomy of Autism Spectrum Disorder Using Normative ModelsMariam Zabihi, Marianne Oldehinkel, Thomas Wolfers, et al.
Journal of Hepatology|June 28, 2011
The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutationJacob Nattermann, Jörg Timm, Hans Dieter Nischalke, et al.
Blood|May 9, 2012
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopeniaVivek L Patel, Matthieu Mahévas, Soo Y Lee, et al.
Blood|October 13, 2007
Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatmentAndreas Hochhaus, Brian Druker, Charles Sawyers, et al.
Pageof 225